Latest Prime Medicine News & Updates

See the latest news and media coverage for Prime Medicine. We track all announcements, press releases, and industry mentions in real time, all in one place.

Prime Medicine

Biotechnology company developing gene-editing therapies

primemedicine.com

Headquarters: Cambridge, United States
Founded year: 2019
Company type: Public company
Number of employees: 200–500
Industry: Pharmaceuticals

Last updated Yesterday

Latest news about Prime Medicine

In short: Prime Medicine dosed first Wilson patient, reported PM359 data, and replaced its CEO amid layoffs.

Company announcements

Yesterday Prime Medicine

FDA releases draft guidance on genetic medicines

Prime Medicine welcomes framework enabling one approval for multiple mutations via in vitro data supplements, advancing rare disease treatments.

September 24 Prime Medicine

Prime Medicine obtains FDA IND clearance for PM647

The investigational Prime Editor targets alpha-1 antitrypsin deficiency. Clinical data expected in 2027.

July 23 Prime Medicine

Prime Medicine obtains FDA clearance for PM577a Wilson disease trial

This clearance enables a global Phase 1/2 program. Prime Medicine expects to initiate the clinical study in late 2026 with initial data anticipated in 2027.

June 18 Prime Medicine

Prime Medicine receives New Zealand clearance for PM577a clinical trial

The clearance enables a global Phase 1/2 study targeting Wilson Disease mutations. Initial data is expected in 2027.

Media coverage

October 5 The Globe and Mail

Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease

-- PM577a targets the H1069Q mutation in the ATP7B gene, the most prevalent WD-causing allele in North America and Europe -- -- Initiation of Phase...

July 28 The Manila Times

Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics

-- Arbitration tribunal declared that PM647 is within Prime Medicine’s "Field”, confirming Prime Medicine’s right to develop and commercialize PM647 in AATD -- -- Prime...

July 15 Yahoo Finance

Prime Medicine (PRME) Reaches Positive Resolution to Arbitration with Beam Therapeutics

Prime Medicine, Inc. (NASDAQ:PRME) is one of the best strong buy penny stocks to invest in now....

July 8 Seeking Alpha

Prime Medicine gains after winning arbitration with Beam Therapeutics

Prime Medicine (PRME) added ~8% in the premarket on Wednesday after an arbitration tribunal sided with the gene editing company in connection with a previously...

Never miss news about Prime Medicine

Track Prime Medicine and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Prime Medicine competitors & trending companies

Browse news for competitors to Prime Medicine and other trending companies.